Moreover, a recent study has shown that the incorporation of TGF-β1 to implants induces the functional phenotype of AF cells and promotes cell proliferation and the synthesis of extracellular matrix (ECM) [22]. The gene discussed is TGFB1; the disease is atrial fibrillation.